Aurobindo Pharma Ltd has posted a consolidated net profit of Rs 92 crore in the third quarter ended December 31.

The Hyderabad-based company incurred a net loss of Rs 28.5 crore in the year-ago period.

The total revenue increased 22 per cent at Rs 1,570 crore (Rs 1284 crore).

The increase in revenue was driven by 22.5 per cent increase in formulation sales at Rs 912 crore.

“We continue to see traction on our performance both in sales and earnings on year-on-year basis on account of improved business mix in formulations from new product approvals and launches in the US market,’’ N. Govindarajan, Managing Director said in a release.

(This article was published on February 7, 2013)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.